Page 1 of 1

Biogen Opicinumab(Anti-LINGO-1) Fails Phase 2 Study of in MS

Posted: Tue Jun 07, 2016 8:20 am
by ton
:sad: Biogen Reports Top-Line Results from Phase 2 Study of Opicinumab (Anti-LINGO-1) in Multiple Sclerosis

http://media.biogen.com/press-release/i ... anti-lingo